Litcius/Paper detail

Aspirin for secondary prevention of cardiovascular disease

Robert A. Byrne, Róisín Colleran

2020The Lancet24 citationsDOI

Topics & Concepts

MedicineAspirinAntithromboticMyocardial infarctionInternal medicineDiseaseClinical trialMeta-analysisStroke (engine)Platelet aggregation inhibitorRandomized controlled trialAdverse effectPrimary preventionSecondary preventionMechanical engineeringEngineeringAntiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction ResearchAtrial Fibrillation Management and Outcomes
Aspirin for secondary prevention of cardiovascular disease | Litcius